The Leadership Team at Cygnal Therapeutics is responsible for setting the strategic direction of the company, guiding its innovative research in exoneural biology, and overseeing the development of novel therapeutic platforms. Composed of founders and seasoned executives in medical, biological, and legal affairs, the team collaborates to drive operational excellence, foster partnerships, and accelerate the advancement of groundbreaking drug candidates.
View all